Establishing correlations between tumor T-cell infiltration and reduction in tumor burden proved to be challenging, as only a limited number of tumors demonstrated a graded response or, in the case of ICOS/PD-1 combination therapy, resulted in small to no tumor detection following weeks of treatment. This evidence concerns the gene ICOS and neoplasm.